Where to Buy Reta in Canada
The place to buy reta in Canada is a Canadian supplier that ships domestic stock and publishes an independent certificate of analysis for it. Vistara Labs supplies Retatrutide (GLP-3), the compound everyone calls reta, as lyophilised research vials shipped from within Canada by Canada Post Xpresspost, with its certificate on our lab reports page. This page covers what reta is, why buying it domestically matters, how to check any reta supplier, and what we stock.
Findings
- Reta is retatrutide, a single peptide that activates three receptors at once: GLP-1, GIP and glucagon. “GLP-3” is a market nickname for the same compound.
- In a 2026 New England Journal of Medicine phase 3 trial of 2,339 adults with obesity, the 12 mg group’s body weight fell 25.0% at 80 weeks, against 3.9% on placebo.
- Buying reta from Canadian stock means a domestic parcel with no customs step, a Canadian business to contact, and a tracked Canada Post delivery.
- Vistara Labs supplies reta as lyophilised vials in 10, 20 and 30 mg sizes and in research stacks, shipped to every province.
View product →What is reta?
Reta is the short name for retatrutide, a synthetic peptide built to activate the GLP-1, GIP and glucagon receptors with a single molecule. The two incretin receptors, GLP-1 and GIP, act on appetite and insulin release; the glucagon receptor adds a lever on energy expenditure and liver fat. That third target is what separates reta from single-receptor compounds such as semaglutide and from the dual GIP and GLP-1 agonist tirzepatide (Coskun et al., Cell Metab, 2022). In early clinical pharmacology its half-life was about six days, which is why trials gave it once weekly (Urva et al., Lancet, 2022).
Reta also travels under the name GLP-3, and our product is listed as Retatrutide (GLP-3) so both searches land on the same vial. There is no natural hormone called GLP-3; What Is Reta (GLP-3)? explains where the name came from.
What the reta research shows
Reta has one of the strongest trial records of any compound in metabolic research. In the 2023 phase 2 trial, 338 adults with obesity were randomised to weekly reta or placebo for 48 weeks; the 12 mg group’s weight fell 24.2% against 2.1% on placebo, and 83% of that group lost at least 15% of body weight (Jastreboff et al., N Engl J Med, 2023). The 2026 phase 3 trial confirmed it at scale: 2,339 adults, 80 weeks, and mean weight change of 17.6%, 23.7% and 25.0% on the 4, 9 and 12 mg doses against 3.9% on placebo, with lower knee osteoarthritis pain and fewer sleep apnea events in the subgroups that had those conditions (Jastreboff et al., N Engl J Med, 2026). Two 2026 Lancet trials extended the picture to type 2 diabetes. The full record is in Reta Weight-Loss Trials and Reta in 2026.
Why buy reta from a Canadian supplier?
Reta is a high-demand compound, and a lot of what is offered online ships from overseas. Buying it from domestic stock changes four practical things.
- No customs step. A parcel that starts and ends in Canada is an ordinary domestic delivery. An international parcel can be held, inspected or returned at the border, and a sealed peptide vial can sit in a depot while that happens. Peptides and customs in Canada covers the difference.
- Less time in transit. Lyophilised reta is stable as a powder, but every extra day in the mail is a day outside controlled storage. A domestic Xpresspost parcel spends far less time in the mail than an international one. Storage windows are in How long does reta last?
- A business you can reach. A Canadian supplier can be contacted directly through a contact page rather than a marketplace inbox.
- Tracking from end to end. Canada Post tracking covers the whole route, from our door to yours, in every province including Ontario, Quebec, British Columbia and Alberta.
How to check a reta supplier
Reta is a long peptide with a fatty-acid side chain, which makes it harder to synthesise than short peptides such as BPC-157. That is exactly why the supplier matters. A credible reta supplier meets every point below.
- It publishes a certificate of analysis for reta specifically. A generic “lab tested” badge is not a certificate.
- The product is labelled honestly. Reta should be described as a research material, with no dosing schedules or medical claims on the listing.
- It ships from Canada. The shipping page should say where orders leave from. “Canadian” on the homepage and an overseas return address on the parcel are not the same thing.
- There is a way to reach a person. A real contact route, answered by the business, is the floor.
Our guide to choosing a peptide vendor in Canada applies the same tests across the catalogue.
Our certificates of analysis are listed by compound on the lab reports page and linked from the reta product page.
Buy reta from Vistara Labs
We supply reta as Retatrutide (GLP-3): lyophilised (freeze-dried) powder in sealed vials, in 10, 20 and 30 mg sizes. Vials are reconstituted for laboratory work with bacteriostatic water; the general method is in how to reconstitute peptides. Reta also appears in two research stacks, the Metabolic Axis and Body Composition. Every order ships from within Canada by Canada Post Xpresspost, which usually arrives in 1 to 3 business days, and several compounds can be combined in one order from the full Canadian peptide catalogue.
Reta is supplied for laboratory research use only. The studies above were clinical research using pharmaceutical preparations.
Is reta legal in Canada?
Reta is not a controlled substance in Canada and holds no Health Canada drug authorization, so it is sold as a laboratory research material and not as a medicine. The detail is in Is Reta Legal in Canada? and, for peptides in general, Are peptides legal in Canada?
How reta compares
Reta is most often weighed against the GLP-1 compounds that came before it. Our side-by-side pages cover reta vs tirzepatide, reta vs semaglutide, reta vs cagrilintide, reta vs tesamorelin and reta vs MOTS-c.
Frequently asked questions
Where can I buy reta in Canada?
Vistara Labs supplies reta as Retatrutide (GLP-3), lyophilised research vials in 10, 20 and 30 mg sizes, shipped from within Canada by Canada Post Xpresspost to every province.
Is reta the same as retatrutide?
Yes. Reta is the short name for retatrutide, and GLP-3 is a market nickname for the same compound. All three names refer to one peptide that activates the GLP-1, GIP and glucagon receptors.
Is reta legal in Canada?
Reta is not a controlled substance in Canada. It has no Health Canada drug authorization, so it is sold as a laboratory research material rather than as a medicine.
Will a reta order go through customs?
No. Every Vistara Labs order ships from within Canada, so there is no customs step and the parcel travels as an ordinary domestic delivery.
How long does a reta order take to arrive?
Orders ship from within Canada by tracked Canada Post Xpresspost, which usually arrives in 1 to 3 business days in every province.
Product details from vistaralabs.ca, October 2026. Sources: Coskun T et al. Cell Metab. 2022. PMID 35985340. Urva S et al. Lancet. 2022. PMID 36354040. Jastreboff AM et al. Triple-hormone-receptor agonist retatrutide for obesity: a phase 2 trial. N Engl J Med. 2023. PMID 37366315. Jastreboff AM et al. Retatrutide, a triple hormone receptor agonist, for treatment of obesity. N Engl J Med. 2026. PMID 42814954.
More on this: Peptides for Weight Loss: What the Research Shows.
All products supplied by Vistara Labs are intended for laboratory research use only. They are not drugs, are not approved for human or veterinary use, and are not intended to diagnose, treat, cure or prevent any condition. Nothing on this page constitutes medical advice or guidance for use in humans.
References
Retatrutide has been evaluated in randomised, placebo-controlled human trials through phase 3.
- Triple-Hormone-Receptor Agonist Retatrutide for Obesity - A Phase 2 TrialRandomised, double-blind, placebo-controlled phase 2 obesity trial, 48 weeks.
- Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USARandomised, double-blind, placebo- and active-controlled phase 2 trial; 281 participants with type 2 diabetes.
- Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trialRandomised phase 2a substudy; 98 participants with metabolic dysfunction-associated steatotic liver disease.
- Efficacy and safety of retatrutide, a GIP, GLP-1, and glucagon receptor agonist, in people with type 2 diabetes and inadequate glycaemic control with diet and exercise: a double-blind, randomised, phase 3 trialDouble-blind randomised phase 3 trial in type 2 diabetes.
Links open the study record on PubMed so the source can be checked directly. Listing a study is not a claim that its findings apply to any other use, product or route of administration. Research use only.